Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.

Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel ...

CHARLESTON, S.C. (WCSC) - The Trump administration started to cut funding from messenger ribonucleic acid vaccine research earlier this month, impacting more than 20 contracts for vaccine development.

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...

RFK Jr., secretary of Health and Human Services, has canceled $500 million of mRNA research funding. The development of the mRNA vaccine is what allowed our country to move out of the COVID-19 ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership aims ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...

CureVac was founded in 2000, and its focus is on developing vaccines and therapies using messenger ribonucleic acid, or mRNA. mRNA offers several advantages, including cell-free, rapid, large-scale ...